These findings indicate that the peptides biological effects are not limited to pituitary GH secretion but may involve broader endocrine and metabolic pathways
GLP-1 receptor agonists (such as semaglutide) mimic the GLP-1 gut hormone and act on GLP-1 receptors throughout the body, including the brain
Platelet counts and concentrations of fasting blood sugar (FBS), hemoglobin A1c (HbA1c), immunoreactive insulin (IRI), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, non-esterified fatty acids (NEFA), aspartate aminotransferase (AST), ALT, -glutamyl transpeptidase, ferritin, and type IV collagen 7 were measured using standard laboratory techniques before and after glutathione treatment
Study design and participants The REDEFINE-1 trial is a large phase 3 study testing treatments for obesity
CAS: 137525-51-2